Lumbar Spine Degeneration Clinical Trial
Official title:
A Multi-Center, Open-Label, Prospective Study of SpinalStimâ„¢ (MOP-SS) as Adjunctive Care Following Lumbar Fusion Surgery
NCT number | NCT03176303 |
Other study ID # | CP-1702SSPM |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 28, 2017 |
Est. completion date | July 12, 2021 |
Verified date | September 2022 |
Source | Orthofix Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study examines the effect of adjunctive use of the SpinalStim bone growth stimulator on lumbar fusion rate in high risk subjects who have had lumbar fusion surgery. All participants will wear the bone growth stimulator for a minimum of 2 hours/day for 6 months.
Status | Completed |
Enrollment | 206 |
Est. completion date | July 12, 2021 |
Est. primary completion date | July 12, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Male or female, = 18 years of age at the time of Informed Consent 2. Requires a lumbar fusion surgery within 30 days of signing Informed Consent. a. Surgical approach is according to physician's discretion. 3. Subject has one or more risk factors: - Is currently using nicotine - multi-level lumbar fusion surgery planned - Prior failed fusion at any lumbar level - Subject reported diabetes - Subject reported osteoporosis 4. Body mass index = 45 kg/m2 at the time of consent. 5. Must have reliable access to an iPhone or an iPad with Wi-Fi access for downloading the free device-specific app (iPhone 5S or higher, iPad, iPad Pro, iPad mini or iTouch using iOS v9.3 or later). When the android version of the mobile app for the SpinalStim becomes available (estimated to be Dec. 2017), subjects who have reliable access to devices using android operating systems will be eligible for study inclusion. 6. Able and willing to complete electronic questionnaires and able to read and understand study instructions in English 7. Able and willing to comply with the study plan and able to understand and sign the study-specific ICF. Exclusion Criteria: 1. Scoliosis greater than 30 degrees 2. Current alcoholism or drug abuse, and/or any known current addiction to pain medications or medical marijuana 3. Any active malignancy or prior history of malignancy within last 5 years prior to fusion (except basal cell carcinoma of the skin). 4. Any clinically significant finding that places the subject at health risk, impacts the study, or affects completion of the study, in the opinion of the Investigator 5. Any psychiatric illness that prevents subject from completing the assessments accurately, in the opinion of the Investigator 6. Prisoners. |
Country | Name | City | State |
---|---|---|---|
United States | ClinTech Center for Spine Health | Johnstown | Colorado |
Lead Sponsor | Collaborator |
---|---|
Orthofix Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | fusion rate | number of subjects with fused lumbar vertebrae, determined by X-rays and CT scans | 12 months | |
Secondary | Device compliance | actual minutes per day device was used compared with prescribed treatment time | 6 months | |
Secondary | revision rate | how many subjects had to be reoperated (revised) at the same level(s) during the course of the study | 12 months | |
Secondary | SF-36 | used to assess the effect of PEMF treatment on subject quality of life | 12 months | |
Secondary | Oswestry Disability Index | used to examine the effect of PEMF treatment on subject disability | 12 months | |
Secondary | VAS pain | used to assess the effect of PEMF treatment on reduction of pain | 12 months | |
Secondary | EQ-5D | used to assess the effect of PEMF treatment on quality of life and economic impact | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04140344 -
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
|
N/A | |
Completed |
NCT04914728 -
Mini-invasive Lumbar Arthrodesis in Ambulatory
|
N/A | |
Recruiting |
NCT05527145 -
Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial
|
N/A | |
Completed |
NCT05630404 -
Efficacy of Surgical Injection Lumbar Erector Spinae Plane Block
|
N/A | |
Recruiting |
NCT05452694 -
OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
|
||
Recruiting |
NCT04823858 -
3Spine Lumbar Fusion Real World Evidence Study
|
||
Recruiting |
NCT06154005 -
OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion
|
Phase 1/Phase 2 | |
Recruiting |
NCT04781517 -
Development of a Patient-reported Outcome Instrument for Patients With Lumbar Degenerative Disease After Lumbar Fusion
|
||
Completed |
NCT03977961 -
The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
|
||
Recruiting |
NCT06462729 -
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
|
Phase 1/Phase 2 | |
Completed |
NCT01143324 -
A Prospective, Multicenter Observational Study on MASTâ„¢ (Minimal Access Spinal Technologies) Fusion Procedures for the Treatment of the Degenerative Lumbar Spine
|
||
Active, not recruiting |
NCT05438719 -
MOTUS Total Joint Replacement Investigational Device Exemption Study
|
N/A | |
Not yet recruiting |
NCT05388383 -
Cost-effectiveness Analysis of Robot-assisted Spinal Surgery
|
||
Completed |
NCT06316921 -
Epidural PCA on Pain Relief After L-spine Surgery
|
||
Completed |
NCT03452449 -
Physical Activity, Disability and Quality of Life Before and After Lumbar Spine Surgery
|
||
Terminated |
NCT03527966 -
rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures
|
Phase 4 | |
Withdrawn |
NCT05408923 -
Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery
|
Phase 4 | |
Terminated |
NCT01415908 -
INFUSE®Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine
|
Phase 3 | |
Completed |
NCT04062942 -
The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)
|
||
Completed |
NCT03088306 -
Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients
|
Early Phase 1 |